Scheme of pharmacotherapy

Scheme of pharmacotherapy. If the theraphy was terminated or changed (e.g., dosage reduced), “Other” shall be selected. Additional textual information should be provided in such a case, see PHARMACOTHERAPY_SCHEME_DESCRIPTION

Validation

Permitted value Language Designation Definition
Scheme of pharmacotherapy - Only preoperatively (no standard): 5-FU 250 mg/m2 i.v. continuous infusion on days 1-13 nad 22-35 and oxaliplatin 50mg/m2 i.v. day 1,8,22 and 29 EN Only preoperatively (no standard): 5-FU 250 mg/m2 i.v. continuous infusion on days 1-13 nad 22-35 and oxaliplatin 50mg/m2 i.v. day 1,8,22 and 29 Scheme of pharmacotherapy - Only preoperatively (no standard): 5-FU 250 mg/m2 i.v. continuous infusion on days 1-13 nad 22-35 and oxaliplatin 50mg/m2 i.v. day 1,8,22 and 29
Scheme of pharmacotherapy - UFT (300-340mg/m2/day) and LV (22.5-90 mg/day) po continuously, 5(-7) days per week, together with radiotherapy EN UFT (300-340mg/m2/day) and LV (22.5-90 mg/day) po continuously, 5(-7) days per week, together with radiotherapy Scheme of pharmacotherapy - UFT (300-340mg/m2/day) and LV (22.5-90 mg/day) po continuously, 5(-7) days per week, together with radiotherapy
Scheme of pharmacotherapy - Capecitabine 800-825 mg/m2 bid po, day 1-5, together with radiation or continuously untill end of radiation EN Capecitabine 800-825 mg/m2 bid po, day 1-5, together with radiation or continuously untill end of radiation Scheme of pharmacotherapy - Capecitabine 800-825 mg/m2 bid po, day 1-5, together with radiation or continuously untill end of radiation
Scheme of pharmacotherapy - 5-FU 1000 mg/m2 i.v. continuous infusion, day 1-5, weeks 1 and 5 EN 5-FU 1000 mg/m2 i.v. continuous infusion, day 1-5, weeks 1 and 5 Scheme of pharmacotherapy - 5-FU 1000 mg/m2 i.v. continuous infusion, day 1-5, weeks 1 and 5
Scheme of pharmacotherapy - 5-FU 225 mg/m2 i.v. continuous infusion, 5 days per week EN 5-FU 225 mg/m2 i.v. continuous infusion, 5 days per week Scheme of pharmacotherapy - 5-FU 225 mg/m2 i.v. continuous infusion, 5 days per week
Scheme of pharmacotherapy - 5-FU 400 mg/m2 + 100 mg i.v. bolus, d 1,2, 11,12,21,22 EN 5-FU 400 mg/m2 + 100 mg i.v. bolus, d 1,2, 11,12,21,22 Scheme of pharmacotherapy - 5-FU 400 mg/m2 + 100 mg i.v. bolus, d 1,2, 11,12,21,22
Scheme of pharmacotherapy - 5-FU 325-350 mg/m2 + LV 20 mg/m2i.v. bolus, day1-5, weeks 1 and 5 EN 5-FU 325-350 mg/m2 + LV 20 mg/m2i.v. bolus, day1-5, weeks 1 and 5 Scheme of pharmacotherapy - 5-FU 325-350 mg/m2 + LV 20 mg/m2i.v. bolus, day1-5, weeks 1 and 5
Other EN Other A scheme of pharmacotherapy which is not mentioned elsewhere on this list

Slots

Name Value
Label PHARMACOTHERAPY_SCHEME
Level REQUIRED
LINK https://academic.oup.com/annonc/article/23/10/2479/195121